Sub menu

Handbook tables

Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease

Age at start of vaccine course MenB vaccine brand Dose requirements for people with a specified medical condition associated with increased risk of meningococcal disease
6 weeks to 5 months Bexsero 4 doses (8 weeks between doses; 4th dose at 12 months of age or 8 weeks after 3rd dose, whichever is later)
6–11 months Bexsero 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later)
12 months to 9 years Bexsero 2 doses (8 weeks between doses)
≥10 years Bexsero 2 doses (8 weeks between doses)
Trumenba 3 doses (at intervals of 0, 1 and 6 months)

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/resources/tables/table-recommendations-for-menb-vaccine-for-people-with-a-specified-medical-condition-that-increases-their-risk-of-invasive-meningococcal-disease

All tables

Link copied

Link, share or bookmark directly to this section of the page.